Skip to content
i2c Pharm
  • Home
  • Services
    • Fast2Clinic™
    • Nasal & Inhalation Formulation
    • Analytical Excellence
    • Gamma Scintigraphy
  • About Us
  • Resources
    • Publications
    • Blogs
  • Contact
Partner With Us
i2c Pharm
  • Home
  • Services
    • Fast2Clinic™
    • Nasal & Inhalation Formulation
    • Analytical Excellence
    • Gamma Scintigraphy
  • About Us
  • Resources
    • Publications
    • Blogs
  • Contact
Partner With Us
i2c Pharm

Resources

The latest scientific publications, regulatory updates, and corporate news from i2c Pharmaceutical Services.

Company News Publications Insights & Blogs

Company News

Press releases, facility updates, and corporate milestones from i2c Pharmaceutical Services.

View All News →
Scintigraphics will be attending DDL 2025 – ...
News
Scintigraphics will be attending DDL 2025 – ...
The Drug Delivery to the Lungs Conference (DDL) is in it’s 34th year and attracts in excess of...
10 Nov 2025 Read more →
Cardiff Scintigraphics / i2c Pharmaceutical Servic...
News
Cardiff Scintigraphics / i2c Pharmaceutical Servic...
Cardiff, UK, Press Release 26th June 2024 Cardiff Scintigraphics has appointed John Pritchard as the new Chairman of...
26 Jun 2024 Read more →
Andrew Brown joins Cardiff Scintigraphics / i2c Ph...
News
Andrew Brown joins Cardiff Scintigraphics / i2c Ph...
Cardiff, UK, Press Release 30 May 2024 Cardiff Scintigraphics has appointed Andrew Brown as the new Chief Executive...
30 May 2024 Read more →

Publications

Peer-reviewed research, whitepapers, and clinical poster presentations authored by our scientific team.

View All Publications →

Lung Deposition of In...

A Gamma Scintigraphy...

Phase I and scintigraphy...

Insights & Blogs

Expert perspectives, technical deep-dives, and industry trends from our formulation and analytical scientists.

Read All Insights →
Understanding HFO-1234ze and HFA-152a: A Formulato...
Blogs
Understanding HFO-1234ze and HFA-152a: A Formulato...
If you are comparing HFO-1234ze vs HFA-152a, the right choice depends on your formulation strategy, device requirements, safety...
17 Apr 2026 Read more →

Ready to Accelerate Your
Inhalation Programme?

From formulation development and analytical testing to gamma scintigraphy and Fast2Clinic manufacturing, i2c's team is ready to discuss your project. Concept to clinic, under one roof.

Get in Touch →
Stay Informed

Inhalation science updates, regulatory insights, and i2c news delivered to your inbox.

1,true,6,Lead Email,2
Thank you. You are now subscribed to i2c updates.

No spam. Unsubscribe at any time. View our Privacy Policy.

i2c Pharmaceutical Services

Independent inhalation R&D services for global pharma, medtech, and emerging clients. Cardiff Medicentre, Wales.

  • Cardiff Medicentre, Heath Park,
    Cardiff, CF14 4UJ, Wales, UK
  • +44 (0) 29 2075 7865
  • info@i2cpharm.co.uk
  • WhatsApp: +44 (0) 7886 147640

Company

  • Home →
  • About Us →
  • Services →
  • Respitab® →
  • Contact →

Services

  • Gamma Scintigraphy →
  • Inhalation & Nasal Dev →
  • Analytical Excellence →
  • Fast2Clinic →

Knowledge

  • News & Events →
  • Publications →
  • Blog →
Respitab®

Could Respitab® be utilised with your formulation?

Learn About Respitab™ →

© 2026 i2c Pharmaceutical Services. All rights reserved. Company Registration No. 02769717  |  VAT Registration No. GB 6157 294 31